NCT00093860View on ClinicalTrials.gov

Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

March 31, 2005

Conditions
Syncope
Interventions
DRUG

Propranolol

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00093860 - Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance | Biotech Hunter | Biotech Hunter